Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-016798
Filing Date
2026-04-15
Accepted
2026-04-15 16:01:16
Documents
103
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 2319705
2 EX-3.9 ex3-9.htm EX-3.9 889
3 EX-10.91 ex10-91.htm EX-10.91 59333
4 EX-10.92 ex10-92.htm EX-10.92 73055
5 EX-31.1 ex31-1.htm EX-31.1 19351
6 EX-31.2 ex31-2.htm EX-31.2 19479
7 EX-32 ex32.htm EX-32 10538
8 GRAPHIC ex3-9_001.jpg GRAPHIC 768490
9 GRAPHIC form10-k_001.jpg GRAPHIC 8391
10 GRAPHIC form10-k_002.jpg GRAPHIC 10468
  Complete submission text file 0001493152-26-016798.txt   12326833

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE bixt-20251231.xsd EX-101.SCH 83527
12 XBRL CALCULATION FILE bixt-20251231_cal.xml EX-101.CAL 68108
13 XBRL DEFINITION FILE bixt-20251231_def.xml EX-101.DEF 388692
14 XBRL LABEL FILE bixt-20251231_lab.xml EX-101.LAB 592188
15 XBRL PRESENTATION FILE bixt-20251231_pre.xml EX-101.PRE 548364
106 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1839223
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35027 | Film No.: 26864096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)